These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2034891)

  • 1. Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattle.
    Delatour P; Garnier F; Benoit E; Caude I
    Res Vet Sci; 1991 Mar; 50(2):134-8. PubMed ID: 2034891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro ruminal biotransformation of benzimidazole sulphoxide anthelmintics: enantioselective sulphoreduction in sheep and cattle.
    Virkel G; Lifschitz A; Pis A; Lanusse C
    J Vet Pharmacol Ther; 2002 Feb; 25(1):15-23. PubMed ID: 11874522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma disposition and faecal excretion of netobimin metabolites and enantiospecific disposition of albendazole sulphoxide produced in ewes.
    Gokbulut C; Cirak VY; Senlik B
    Vet Res Commun; 2006 Oct; 30(7):791-805. PubMed ID: 17004041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspects of the pharmacokinetics of albendazole sulphoxide in sheep.
    Goudah A
    Vet Res Commun; 2003 Oct; 27(7):555-66. PubMed ID: 14609267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics and bioavailability of albendazole sulfoxide in sheep and goats, and dose-dependent plasma disposition in goats.
    Aksit D; Yalinkilinc HS; Sekkin S; Boyacioğlu M; Cirak VY; Ayaz E; Gokbulut C
    BMC Vet Res; 2015 May; 11():124. PubMed ID: 26012791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats.
    Delatour P; Benoit E; Besse S; Boukraa A
    Xenobiotica; 1991 Feb; 21(2):217-21. PubMed ID: 2058177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetic behaviour of albendazole in sheep and goats.
    Hennessy DR; Sangster NC; Steel JW; Collins GH
    Int J Parasitol; 1993 May; 23(3):321-5. PubMed ID: 8359981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of repeated doses of albendazole on enantiomerism of its sulfoxide metabolite in goats.
    Benoit E; Besse S; Delatour P
    Am J Vet Res; 1992 Sep; 53(9):1663-5. PubMed ID: 1416373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albendazole sulphoxide enantiomeric ratios in plasma and target tissues after intravenous administration of ricobendazole to cattle.
    Cristofol C; Virkel G; Alvarez L; Sánchez S; Arboix M; Lanusse C
    J Vet Pharmacol Ther; 2001 Apr; 24(2):117-24. PubMed ID: 11442786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chirality of the sulphoxide metabolites of fenbendazole and albendazole in sheep.
    Delatour P; Benoit E; Garnier F; Besse S
    J Vet Pharmacol Ther; 1990 Dec; 13(4):361-6. PubMed ID: 2287028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetic behaviour in sheep.
    Alvarez LI; Sánchez SF; Lanusse CE
    J Vet Pharmacol Ther; 1999 Apr; 22(2):77-86. PubMed ID: 10372592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver microsomal biotransformation of albendazole in deer, cattle, sheep and pig and some related wild breeds.
    Velík J; Baliharová V; Skálová L; Szotáková B; Wsól V; Lamka J
    J Vet Pharmacol Ther; 2005 Aug; 28(4):377-84. PubMed ID: 16050818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of albendazole and albendazole sulphoxide by Haemonchus contortus and Fasciola hepatica in sheep.
    Alvarez LI; Imperiale FA; Sánchez SF; Murno GA; Lanusse CE
    Vet Parasitol; 2000 Dec; 94(1-2):75-89. PubMed ID: 11078946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats.
    Capece BP; Castells G; Godoy C; Arboix M; Cristòfol C
    Vet J; 2008 Aug; 177(2):297-9. PubMed ID: 17566773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic behaviour of albendazole sulphoxide enantiomers in male and female sheep.
    Capece BP; Castells G; Pérez F; Arboix M; Cristòfol C
    Vet Res Commun; 2000 Jul; 24(5):339-48. PubMed ID: 10868551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative sulphoxidation of albendazole by sheep and cattle liver microsomes and the inhibitory effect of methimazole.
    Lanusse CE; Nare B; Prichard RK
    Xenobiotica; 1993 Mar; 23(3):285-95. PubMed ID: 8498091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys.
    Gokbulut C; Akar F; McKellar QA
    Vet J; 2006 Jul; 172(1):166-72. PubMed ID: 16772142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics in sheep and cattle of albendazole administered by an intraruminal slow release capsule.
    Delatour P; Benoit E; Lechenet J; Besse S
    Res Vet Sci; 1990 May; 48(3):271-5. PubMed ID: 2359877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I biotransformation of albendazole in lancet fluke (Dicrocoelium dendriticum).
    Cvilink V; Szotáková B; Krízová V; Lamka J; Skálová L
    Res Vet Sci; 2009 Feb; 86(1):49-55. PubMed ID: 18565554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified plasma and abomasal disposition of albendazole in nematode-infected sheep.
    Alvarez LI; Sánchez SF; Lanusse CE
    Vet Parasitol; 1997 May; 69(3-4):241-53. PubMed ID: 9195734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.